Wanja Kassuhn

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging

P. Jank, S. Darb-Esfahani, J. Sehouli, 2020, Geburtshilfe und Frauenheilkunde.

Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging

J. George, D. Bowtell, N. Blüthgen, 2021, Cancers.

Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.

I. Vergote, J. Sehouli, H. Kulbe, 2022, Gynecologic Oncology.

In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients

N. Blüthgen, J. Sehouli, P. Cutillas, 2023, Cancers.